investing

The year 2026 is shaping up as a strategic choice phase for listed luxury companies. After an extraordinary expansion cycle between 2021 and 2023, followed by normalization in 2024–2025, the sector is entering a more disciplined environment. In this context, financial institutions like JPMorgan and HSBC have identified specific opportunities grounded in two core pillars: structural brand strength and financial resilience amid mixed global economic conditions.

Innovation in healthcare is attracting strong interest in the investment community. Cutivue™, a mobile app leveraging AI for early detection of skin cancer, has launched its Pre-Seed round of €200,000. The structure: 10 qualified investors, each contributing €20,000, will obtain an individual 5% stake (50% in total).
With a differentiated approach — on-device AI, privacy by default, and global scalability — Cutivue™ positions itself as a strategic asset at the intersection of technology, digital health, and preventive care.














